6533b83afe1ef96bd12a7bd6
RESEARCH PRODUCT
Prognosis of Patients Listed for a Heart Transplant During the Pretransplant Period: Does Diabetes Matter?
Gerdi WeidnerJacqueline M. SmitsUwe SchulzJan GummertMichael WeyandHeike SpadernaThomas KubiakMiriam Hemmersbachsubject
AdultMalemedicine.medical_specialtyPediatricsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTreatment outcomeInformed consentDiabetes mellitusDiabetes MellitusInternal MedicinemedicineHumansOnline Letters: ObservationsHeart FailureAdvanced and Specialized NursingHeart transplantationbusiness.industryMiddle AgedPrognosismedicine.diseaseSurgeryTreatment OutcomeWaiting listHeart failureHeart TransplantationFemaleObservational studybusinessdescription
Whether patients with advanced heart failure and diabetes mellitus (DM) should be listed for heart transplantation (HTx) remains controversial due to conflicting findings regarding their post-HTx survival (1–3). We studied HTx candidates with and without DM during the pre-HTx period, examining multiple waiting list outcomes. Patients were enrolled in the Waiting for a New Heart Study, a multisite observational study of 318 adult (≥18 years of age) patients (aged 53 ± 11 years; 18% female) who were newly listed for HTx with Eurotransplant between April 2005 and December 2006 (4). Informed consent and ethics approval were obtained (4). Characteristics at the time of listing included age, DM, and the Heart Failure Survival Score (1). Outcomes were mechanical circulatory support (MCS) device implantation, death combined with delisting due to clinical deterioration, high urgency HTx, and elective HTx. There were 288 patients (75 with DM, 213 without …
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2013-03-01 | Diabetes Care |